96 related articles for article (PubMed ID: 11597773)
41. Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice.
Crochemore C; Peña-Altamira E; Virgili M; Monti B; Contestabile A
Neurochem Int; 2005 Apr; 46(5):357-68. PubMed ID: 15737434
[TBL] [Abstract][Full Text] [Related]
42. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
43. Induction of c-Jun immunoreactivity in spinal cord and brainstem neurons in a transgenic mouse model for amyotrophic lateral sclerosis.
Jaarsma D; Holstege JC; Troost D; Davis M; Kennis J; Haasdijk ED; de Jong VJ
Neurosci Lett; 1996 Nov; 219(3):179-82. PubMed ID: 8971809
[TBL] [Abstract][Full Text] [Related]
44. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
[TBL] [Abstract][Full Text] [Related]
45. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
46. Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis.
Sone J; Niwa J; Kawai K; Ishigaki S; Yamada S; Adachi H; Katsuno M; Tanaka F; Doyu M; Sobue G
J Neurosci Res; 2010 Jan; 88(1):123-35. PubMed ID: 19610091
[TBL] [Abstract][Full Text] [Related]
47. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis.
Wang Q; Zhang X; Chen S; Zhang X; Zhang S; Youdium M; Le W
Neurodegener Dis; 2011; 8(5):310-21. PubMed ID: 21346313
[TBL] [Abstract][Full Text] [Related]
48. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Sharp PS; Dick JR; Greensmith L
Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
[TBL] [Abstract][Full Text] [Related]
49. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
50. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
51. Perturbations of the Proteome and of Secreted Metabolites in Primary Astrocytes from the hSOD1(G93A) ALS Mouse Model.
Stella R; Bonadio RS; Cagnin S; Massimino ML; Bertoli A; Peggion C
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209958
[TBL] [Abstract][Full Text] [Related]
52. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
53. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
Kadoyama K; Funakoshi H; Ohya-Shimada W; Nakamura T; Matsumoto K; Matsuyama S; Nakamura T
Neurosci Res; 2009 Oct; 65(2):194-200. PubMed ID: 19595710
[TBL] [Abstract][Full Text] [Related]
54. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS.
Ghoddoussi F; Galloway MP; Jambekar A; Bame M; Needleman R; Brusilow WS
J Neurol Sci; 2010 Mar; 290(1-2):41-7. PubMed ID: 20060132
[TBL] [Abstract][Full Text] [Related]
55. ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.
Lemarchant S; Pomeshchik Y; Kidin I; Kärkkäinen V; Valonen P; Lehtonen S; Goldsteins G; Malm T; Kanninen K; Koistinaho J
Mol Neurodegener; 2016 Jan; 11():10. PubMed ID: 26809777
[TBL] [Abstract][Full Text] [Related]
56. RNAi knockdown of Par-4 inhibits neurosynaptic degeneration in ALS-linked mice.
Xie J; Awad KS; Guo Q
J Neurochem; 2005 Jan; 92(1):59-71. PubMed ID: 15606896
[TBL] [Abstract][Full Text] [Related]
57. Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.
Malaspina A; Ngoh SF; Ward RE; Hall JC; Tai FW; Yip PK; Jones C; Jokic N; Averill SA; Michael-Titus AT; Priestley JV
Neuroscience; 2010 Aug; 169(2):812-27. PubMed ID: 20470869
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
59. Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.
Nichols NL; Satriotomo I; Harrigan DJ; Mitchell GS
Exp Neurol; 2015 Nov; 273():138-50. PubMed ID: 26287750
[TBL] [Abstract][Full Text] [Related]
60. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
